Mr. Miguel Martin reports

AURORA CANNABIS TO HOST FOURTH QUARTER AND FISCAL YEAR 2026 INVESTOR CONFERENCE CALL AND FILE RELATED YEAR END INFORMATION

Aurora Cannabis Inc. has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2026 on Thursday, June 11, 2026, at 8 a.m. Eastern Time or 6 a.m. Mountain Time. The company will report its financial results for the fourth quarter and fiscal year 2026 before the opening of markets that same day.

Conference call details

Date:  Thursday, June 11, 2026

Time:  8 a.m. Eastern Time or 6 a.m. Mountain Time

A webcast will be available.

Miguel Martin, executive chairman and chief executive officer, and Simona King, chief financial officer, will host the conference call and question-and-answer period. A Web link has also been posted to the company's website under events.

About Aurora Cannabis Inc.

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia and New Zealand with a portfolio of trusted, leading brands including Aurora, MedReleaf, Pedanios, IndiMed, San Raf and Whistler Medical Marijuana Corp. With world-class good-manufacturing-practice-certified manufacturing facilities in Canada and Germany and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of opening the world to cannabis.

Aurora's common shares trade on Nasdaq and Toronto Stock Exchange under the symbol ACB.

We seek Safe Harbor.